References
- National Asthma Education and Prevention Program expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda: US Dept of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 1997; NIH publication 97–4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed Feb 25, 2005
- National Asthma Education and Prevention Program expert panel report: guidelines for the diagnosis and management of asthma—update on selected topics 2002. Bethesda: US Dept of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 2002; NIH publication 02–5075. Available at: http://nhlbi.nih.gov/guidelines/asthma/execsumm.pdf. Accessed Feb 25, 2005
- Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343(5): 332–6
- Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995; 332(13): 868–75
- British guidelines on the management of asthma: a national clinical guideline. Rev. London: British Thoracic Society and Scottish Intercollegiate Guidelines Network, 2004. Available at: http://www.brit-thoracic.org.uk/docs/asthmafull.pdf. Accessed Mar 15, 2005
- Powell H, Gibson PG. High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children. Cochrane Database Syst Rev 2004; 2: CD004109
- Pedersen S, O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997; 52(39 Suppl): 1–34
- Masoli M, Holt S, Weatherall M, et al. The dose-response relationship of inhaled corticosteroids in asthma. Curr Allergy Asthma Rep 2004; 4(2): 144–8
- Holt S, Suder A, Weatherall M, et al. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ 2001; 323(7307): 253–6